{{Drugbox
| Verifiedfields = 
| Watchedfields = 
| verifiedrevid = 
| IUPAC_name = [(1R,4aS,4bS,10aR,10bS,11S,12aS)-1-acetyl-11-hydroxy-10a,12a-dimethyl-8-oxo-2,3,4,4a,4b,5,6,10b,11,12-decahydrochrysen-1-yl] butanoate
| image = 
| width = 

<!--Clinical data-->
| tradename = Stermonid
| pregnancy_AU = <!-- A / B1 / B2 / B3 / C / D / X -->
| pregnancy_US = <!-- A / B            / C / D / X -->
| pregnancy_category = 
| legal_AU = <!-- Unscheduled / S2 / S3 / S4 / S5 / S6 / S7 / S8 / S9 -->
| legal_CA = 
| legal_UK = 
| legal_US = 
| legal_status = 
| routes_of_administration = [[Topical medication|Topical]]

<!--Pharmacokinetic data-->
| bioavailability = 
| protein_bound = 
| metabolism = 
| elimination_half-life = 
| excretion =

<!-- Identifiers -->
| CAS_number_Ref = 
| CAS_number = 66877-67-6
| CAS_supplemental = 
| class = [[Corticosteroid]]; [[Glucocorticoid]]
| ATC_prefix = 
| ATC_suffix = 
| ATC_supplemental = 
| PubChem = 68868
| IUPHAR_ligand = 
| DrugBank_Ref = 
| DrugBank = 
| ChemSpiderID_Ref = 
| ChemSpiderID = 62100
| UNII = 910G0QIM2M
| KEGG = 
| ChEBI = 
| ChEMBL = 2106538

<!--Chemical data-->
| C=26 | H=36 | O=5
| molecular_weight = 428.569 g/mol
| SMILES = CCCC(=O)O[C@@]1(CCC[C@@H]2[C@@]1(C[C@@H]([C@H]3[C@H]2CCC4=CC(=O)C=C[C@]34C)O)C)C(=O)C
| StdInChI_Ref = 
| StdInChI = 1S/C26H36O5/c1-5-7-22(30)31-26(16(2)27)12-6-8-20-19-10-9-17-14-18(28)11-13-24(17,3)23(19)21(29)15-25(20,26)4/h11,13-14,19-21,23,29H,5-10,12,15H2,1-4H3/t19-,20-,21-,23+,24-,25-,26-/m0/s1
| StdInChIKey_Ref = 
| StdInChIKey = IYBYNRHXGXDDDS-VRRJBYJJSA-N
| synonyms = Ro 12-7024; 11β-Hydroxy-D-homopregna-1,4-diene-3,20-dione 17α-butyrate
}}

'''Domoprednate''' (brand name '''Stermonid'''; developmental code name '''Ro 12-7024''') is a [[synthetic compound|synthetic]] [[glucocorticoid]] [[corticosteroid]] which was developed in the late 1970s and 1980s.<ref name="Elks2014">{{cite book|author=J. Elks|title=The Dictionary of Drugs: Chemical Data: Chemical Data, Structures and Bibliographies|url=https://books.google.com/books?id=0vXTBwAAQBAJ&pg=PA465|date=14 November 2014|publisher=Springer|isbn=978-1-4757-2085-3|pages=465–}}</ref><ref name="pmid6370748">{{cite journal | vauthors = Schmidt H, Hjorth N, Holm P | title = A randomized trial on the D-homosteroid domoprednate (Ro 12-7024) in the treatment of dermatoses | journal = Dermatologica | volume = 168 | issue = 3 | pages = 127–30 | year = 1984 | pmid = 6370748 | doi = | url = }}</ref><ref name="pmid3888708">{{cite journal | vauthors = Serup J, Holm P | title = Domoprednate (Stermonid), a topical D-homocorticosteroid, skin atrophy and telangiectasia. A double-blind, randomized comparison with hydrocortisone butyrate, betamethasone valerate, clobetasole propionate and placebo | journal = Dermatologica | volume = 170 | issue = 4 | pages = 189–94 | year = 1985 | pmid = 3888708 | doi = | url = }}</ref><ref name="pmid3888709">{{cite journal | vauthors = Christiansen JV, Foged E, Holm P, Jørgensen AS, Reymann F | title = The treatment of psoriasis with 0.1% domoprednate (a D-homocorticosteroid) and 0.1% betamethasone valerate ointment. A double-blind, randomized trial | journal = Dermatologica | volume = 170 | issue = 4 | pages = 195–8 | year = 1985 | pmid = 3888709 | doi = | url = }}</ref><ref name="pmid3653463">{{cite journal | vauthors = Schmidt H, Hjorth N, Holm P | title = Domoprednate, a new nonhalogenated topical steroid: comparison to hydrocortisone butyrate | journal = Dermatologica | volume = 175 | issue = 3 | pages = 145–7 | year = 1987 | pmid = 3653463 | doi = | url = }}</ref>

==References==
{{Reflist|2}}


{{Glucocorticoids and antiglucocorticoids}}
{{Glucocorticoid receptor modulators}}

[[Category:Alcohols]]
[[Category:Butyrates]]
[[Category:Diketones]]
[[Category:Esters]]
[[Category:Glucocorticoids]]
[[Category:Pregnanes]]


{{steroid-stub}}